GlobeNewsWire
10 Jun 2026, 02:49 UTC · 8h ago
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
GlobeNewsWire
10 Jun 2026, 02:49 UTC · 8h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
What the story claims
3 claims · each scored for market impact
Tango Therapeutics has priced an upsized public offering expected to raise approximately $600 million. — Public offerings typically cause immediate share price dilution for existing shareholders.
-0.40Underwriters have been granted a 30-day option to purchase up to an additional 3,000,009 shares. — This creates potential for further dilution if the option is exercised.
-0.10The offering price for the common stock has been set at $30.00 per share. — The pricing provides a concrete valuation benchmark but is a neutral mechanical detail of the capital raise.
+0.00Which stocks this story touches
Continue reading
6 related stories
The company is successfully raising $600 million in capital through an upsized public offering to fund its clinical-stage operations.
The company is acting as a joint bookrunning manager for a significant capital raise, generating fee income.
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 10 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
PRNewsWire
1d ago
